Feng Zhang

This inventor holds 190 USPTO granted patents and 210 published patent applications, plus 1 CIPO patent and 69 EPO patents, primarily in CRISPR Technology (CPC class C12N9-22). Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., Harvard College. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Feng Zhang. Retrieved from https://idiyas.com/inventor/feng-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 190 (Patent Applications = 210)

% Patents Active = 92.1

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 69 (Patent Applications = 155)

Average Co-Inventor Count = 3.2

ph-index = 38

Forward Citations = 9,318(Granted Patents)

Forward Citations (Not Self Cited) = 7,680(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Stanford, CA (US) (2016)
Cambridge, MA (US) (2008 - 2024)

Company Filing History:

149 out of 8,608

Massachusetts Institute of Technology

patents

146 out of 490

The Broad Institute, Inc.

Leland Stanford Junior University

patents

5. 9 out of 3,705

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

6. 7 out of 1,499

Rutgers, The State University of New Jersey

patents

7. 7 out of 925

University of Iowa Research Foundation

patents

8. 6 out of 11

Skolkovo Institute of Science and Technology

patents

9. 6 out of 1,363

The University of Tokyo

patents

10. 4 out of 54

Editas Medicine, Inc.

patents

11. 3 out of 7

The Board Institute, Inc.

patents

12. 2 out of 1,077

Children's Medical Center Corporation

patents

13. 2 out of 751

The Rockefeller University

patents

14. 1 out of 1,272

Dana-Farber-Cancer Institute Inc.

patents

15. 1 out of 15

Instituto Carlos Slim De La Salud, A.c.

patents

16. 1 out of 277

Massachusetts Eye and Ear Infirmary

patents

17. 1 out of 6

President and Fellows of Havard College

patents

18. 1 out of 3,080

The General Hospital Corporation

University of Pittsburgh

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

Areas of Expertise:

CRISPR Systems

Gene Editing

Functional Genomics

Diagnostics

Nucleic Acid Editing

Antiviral Therapy

Guide RNAs

Transposase

Enzymes

Payload Delivery

Class 2 CRISPR-Cas

Microglial Progenitors

190 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12781245 - DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs) (2026-11-03),

2. 12767986 - CRISPR effector system based diagnostics (2026-10-20),

3. 12760297 - CRISPR/Cas-cytidine deaminase based compositions, systems, and methods for targeted nucleic acid editing (2026-10-13),

4. 12760285 - NOVEL CRISPR ENZYMES AND SYSTEMS (2026-10-13),

5. 12753406 - CAS12B enzymes and systems (2026-10-06),

6. 12736526 - Three-Dimensional Human Neural Tissues for CRISPR-Mediated Perturbation of Disease Genes (2026-09-15),

7. 12698491 - NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS (2026-08-04),

8. 12686862 - CRISPR enzymes and systems (2026-07-21),

9. 12662667 - CRISPR enzymes and systems (2026-06-23),

10. 12655403 - Systems, methods, and compositions for targeted nucleic acid editing (2026-06-16),

11. 12644136 - DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs) (2026-06-02),

12. 12644111 - CRISPR enzymes and systems (2026-06-02),

13. 12630867 - Devices for CRISPR effector system based diagnostics (2026-05-19),

14. 12606815 - Self-diversifying systems and methods of use thereof (2026-04-21),

15. 12595478 - CRISPR-CAS SYSTEMS HAVING DESTABILIZATION DOMAIN (2026-04-07),

Title: The Innovative Journey of Inventor Feng Zhang

Introduction: Feng Zhang is a renowned inventor based in Cambridge, MA (US) known for his groundbreaking contributions to the field of biotechnology and genome editing.

Latest Patents: Feng Zhang holds several patents related to CRISPR-Cas9 technology, a revolutionary tool for editing genes. His recent patents focus on enhancing the precision and efficiency of gene editing techniques.

Career Highlights: Feng Zhang is a core member of the Broad Institute of MIT and Harvard, where he leads a research lab dedicated to developing innovative genome editing technologies. He is also a professor at the Massachusetts Institute of Technology (MIT), where he imparts his knowledge to the next generation of scientists.

Collaborations: Feng Zhang has collaborated with leading biotech companies, research institutions, and universities worldwide to further advance the field of genome editing. His collaborative efforts have resulted in significant advancements in the application of CRISPR-Cas9 technology.

Conclusion: Feng Zhang's relentless pursuit of innovation in genome editing has positioned him as a trailblazer in the scientific community. His patents and research continue to shape the future of biotechnology and hold promise for groundbreaking discoveries in the years to come.

Profile summary based on public USPTO records.